- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
- Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives
- Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
Copyright, Project CBD. If you wish to reproduce any of the content on this site, please contact us for reprint permission.